1 study on Membrane disrupting mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research highlights the significant potential of LL-37-Mod1 as a novel therapeutic agent against the growing threat of multidrug-resistant bacterial infections. Its rapid bactericidal action and membrane-disrupti…